Peak Proteins is delighted to have contributed to a poster at ELRIG UK 2019 titled “Spider vs Snakes – discovery of novel snake venom protease inhibitors from spider venom” in collaboration with  Venomtech Limited.

Mark Abbott, Hazel Weir and Rachel Rowlinson are all attending the conference.

“ELRIG is always such a thought-provoking conference and this year we are thrilled to have our protein mass spectrometry service highlighted in a poster by our clients, Venomtech.  Venomtech is a biotechnology company based in Sandwich, UK, who focuses on developing novel venom-derived screening tools, and lead compounds. Working together has been incredibly interesting”, commented Mark, Chief Executive Officer of Peak Proteins.

Steven Trim, Chief Scientific Officer of Venomtech added, “Peak Proteins are the best providers of mass spectrometry data identification we have found for delivering high quality data in a fast commercially viable timeframe”.

Now in its 13th year, ELRIG’s flagship conference Drug Discovery 2019 will take place at ACC Conference Centre by The Port of Liverpool, UK, from the 5th to the 6th of November.  This year’s focus, ‘A Look Back to the Future’ is planned to include plenary introductions assessing “how we got to where we are now and setting the challenges for discovering the drugs of the future”.

Drug Discovery has become the largest meeting of life sciences industry professionals in the UK. This 2-day event will bring together more than 1200 delegates and over 100 exhibiting companies from around the world.  Find out more about the Drug Discovery 2019 – Looking Back to The Future program here.